China grants country’s first COVID-19 vaccine patent to CanSino: state media

Published 6y ago

BEIJING (Reuters) – China’s vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country’s intellectual property regulator. It is the first ... More »